Glasgow, United Kingdom – Tuesday 3 February 2026 – Sistemic Ltd, a Glasgow-based advanced molecular diagnostics company specialising in stem cell characterisation, welcomed Richard Lochhead MSP, Minister for Business and Employment, to its facilities for a ministerial visit focused on Scotland’s role in advancing safe and effective cell and gene therapies. The visit recognised Sistemic’sContinueContinue reading “Innovation Leader in Cell Therapy, Sistemic, welcomes visit from Minister for Business and Employment”
Author Archives: marcelsistemic
Sistemic Joins UK Consortium to Advance Universal Safety Test for Stem Cell Therapies
Glasgow, United Kingdom, [Wednesday 10th December 2025] Sistemic is an advanced molecular diagnostic company, based in Glasgow, focused on the Cell Therapy Industry which has evolved over the past decade and now has the potential to develop into a multibillion-dollar global industry. However, Cell Therapy Products are complex and can be exquisitely sensitive to changesContinueContinue reading “Sistemic Joins UK Consortium to Advance Universal Safety Test for Stem Cell Therapies”
Sistemic’s SistemPSCCheck™ assay meets new guidelines released by International Society for Stem Cell Research (ISSCR) for stem cell research.
Release Date: 14 August 2023 This week, the International Society for Stem Cell Research (ISSCR) released a new set of guidelines and standards in an effort to improve the rigor and reproducibility of data obtained from human stem cell research. The ISSCR is the most prominent international stem cell research society that have previously governedContinueContinue reading “Sistemic’s SistemPSCCheck™ assay meets new guidelines released by International Society for Stem Cell Research (ISSCR) for stem cell research.”
Sistemic Ltd announce expansion of patent portfolio covering the use of microRNAs as predictive analytes for cellular function.
Release Date: July 16th, 2020 Glasgow, United Kingdom; 16th July 2020: Sistemic Ltd. is pleased to announce that it has received Notification of Intention to Grant by the United Kingdom Intellectual Property Office (UKIPO) for the patent application entitled “Functional Prediction of MSCs” (UK Patent Application No. 1608086.3). The Notification of Intention to Grant isContinueContinue reading “Sistemic Ltd announce expansion of patent portfolio covering the use of microRNAs as predictive analytes for cellular function.“